PPD (PPD) Stock Price

PPD Price

🇺🇸NASDAQ·CLOSED
47.28USD
Market closed
Today +/-
Today %

PPD (PPD) Stock | ISIN US69355F1021 | WKN A2PX5V. The current PPD stock price is 47.28 USD (2026). Market capitalization is 16.55 B USD. PPD operates in the Health sector.

Revenue has compounded at 15% per year over the past 4 years to 4.68 B USD. Earnings per share have declined at 4.8% per year over the last 4 years. PPD's net margin stands at 3.3%, down from 6.8% several years earlier.

PPD stock price

Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of PPD over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how PPD stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing PPD's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

PPD Stock Price History
DatePPD Price
Access this data via the Eulerpool API

PPD Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2016
2.68 B USD
314.3 M USD
183.1 M USD
Jan 1, 2017
3 B USD
376.1 M USD
296 M USD
Jan 1, 2018
3.75 B USD
402.2 M USD
104.2 M USD
Jan 1, 2019
4.03 B USD
418.5 M USD
47.8 M USD
Jan 1, 2020
4.68 B USD
509.4 M USD
153.7 M USD
Invalid Date
6.07 B USD
0 USD
567.11 M USD
Invalid Date
6.43 B USD
0 USD
644.42 M USD
Invalid Date
7.02 B USD
0 USD
736.11 M USD
Invalid Date
7.47 B USD
0 USD
830.35 M USD
Invalid Date
8.03 B USD
0 USD
946.02 M USD

PPD Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jun 20, 2026, 3:17 AM
 
REVENUE (B USD)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (B USD)
NET INCOME (M USD)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
2018201920202021e2022e2023e2024e2025e
3.754.034.686.076.437.027.478.03
24.937.5216.1329.765.939.116.457.51
39.3240.2438.4129.627.9525.6124.0622.38
1.471.621.81.81.81.81.81.8
10447153567644736830946
-64.86-54.81225.53270.5913.5814.2912.7713.98
327328.6346.7346.7346.7346.7346.7346.7
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales PPD generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue PPD retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare PPD's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares PPD has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against PPD's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

PPD stock margins

The PPD margin analysis displays the gross margin, EBIT margin, as well as the profit margin of PPD. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for PPD.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2016
48.25 %
11.73 %
6.83 %
Jan 1, 2017
48.8 %
12.53 %
9.86 %
Jan 1, 2018
39.32 %
10.73 %
2.78 %
Jan 1, 2019
40.24 %
10.38 %
1.19 %
Jan 1, 2020
38.42 %
10.88 %
3.28 %
Invalid Date
38.42 %
0 %
9.34 %
Invalid Date
38.42 %
0 %
10.02 %
Invalid Date
38.42 %
0 %
10.49 %

PPD Stock Revenue, EBIT, Earnings per Share

The PPD earnings per share therefore indicates how much revenue PPD has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2016
7.9 USD
0.93 USD
0.54 USD
Jan 1, 2017
8.84 USD
1.11 USD
0.87 USD
Jan 1, 2018
11.46 USD
1.23 USD
0.32 USD
Jan 1, 2019
12.27 USD
1.27 USD
0.15 USD
Jan 1, 2020
13.5 USD
1.47 USD
0.44 USD
Invalid Date
17.35 USD
0 USD
1.62 USD
Invalid Date
18.38 USD
0 USD
1.84 USD
Invalid Date
20.05 USD
0 USD
2.1 USD

PPD business model & stock analysis

PPD Inc is a global company for medical research and services that was founded in 1985 and is headquartered in Wilmington, North Carolina, USA. The company is known for its ability to conduct clinical trials and develop research programs for the biopharmaceutical and medical industry. PPD is a leading provider of comprehensive, integrated services for phases I-IV of clinical research, from non-interventional studies to contract research for pharmaceutical and biotech clients. PPD's business model is based on three key pillars to provide customers with a broad portfolio of services: the first pillar is comprehensive clinical research required for drug registration with regulatory authorities, the second pillar focuses on providing research-based data and analytical methods to facilitate decision-making and risk assessment in the healthcare sector, and the third pillar encompasses extensive laboratory analyses and diagnostic tests to improve patient health and support research efforts. PPD has multiple divisions focused on specific markets and customers. The Clinical Trials division offers services for drug development up to approval by regulatory authorities, including the setup and monitoring of clinical trials and statistical analysis of test results. The Data Management division provides data capture and management solutions for clinical trials to ensure high data quality and compliance with regulations. The Medical Monitoring division offers medical consultation and monitoring during clinical trials. PPD also has a division for Real World Evidence studies, which collects data from routine clinical practice to assess the safety and efficacy of drugs. PPD has made some important acquisitions in the past to strengthen its presence in the industry. In 2011, PPD was acquired by private equity firms Carlyle Group and Hellman & Friedman, becoming a private company. In 2020, PPD went public. In 2018, PPD acquired Evidera, a company specializing in clinical epidemiology and outcomes research. In 2019, PPD acquired Q-Squared Solutions, expanding its extensive laboratory analysis and diagnostic testing capabilities. PPD's offerings include a wide range of products and services, including unique planning and implementation solutions that enable efficient conduct of clinical trials. These solutions also include electronic data capture and management systems, as well as statistical analysis tools. PPD also offers specialized services, such as training programs for clinical investigators and staff. PPD aims to enable safe, faster, and cost-effective drug development through clinical research. In the future, PPD will continue to expand its business model and services to meet the needs of its customers in the changing industry and support innovative research programs.

PPD SWOT Analysis

Strengths

PPD Inc. possesses several key strengths that contribute to its success and competitive advantage:

  • Strong reputation and brand recognition in the industry.
  • Diverse portfolio of products and services, catering to various market segments.
  • Well-established distribution network, ensuring wide market coverage.
  • Highly skilled and experienced workforce, fostering innovation and efficiency.

Weaknesses

Despite its strengths, PPD Inc. also faces certain weaknesses that pose challenges:

  • Reliance on a limited number of key customers, increasing vulnerability to changes in their preferences or market conditions.
  • Higher operational costs compared to some competitors.
  • Limited geographic reach, potentially missing out on untapped markets.
  • Integration and communication challenges across different departments and divisions within the organization.

Opportunities

PPD Inc. has identified several opportunities that it can capitalize on:

  • Expanding into emerging markets with high growth potential.
  • Developing new and innovative products to meet evolving customer needs.
  • Acquiring smaller competitors to strengthen market position and increase market share.
  • Forming strategic partnerships or collaborations to access new technologies or markets.

Threats

PPD Inc. also faces certain threats that may impact its growth and profitability:

  • Intense competition from existing and new players in the market.
  • Changing regulatory landscapes and compliance requirements.
  • Economic downturns or fluctuations, affecting customer spending and demand.
  • Rapid technological advancements, necessitating continuous adaptation and investment.

PPD Eulerpool Fair Value

PPD historical P/E ratio, EBIT multiple, and P/S ratio

PPD annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

PPD shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2016
339.4 M base_Shares
Jan 1, 2017
339.4 M base_Shares
Jan 1, 2018
327 M base_Shares
Jan 1, 2019
328.6 M base_Shares
Jan 1, 2020
346.7 M base_Shares
Invalid Date
346.7 M base_Shares
Invalid Date
346.7 M base_Shares
Invalid Date
346.7 M base_Shares
Price targets and forecasts for PPD are not yet available.

PPD Earnings Estimates

PPD Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
3/1/20220.45USD1.49 BUSD2021 Q4
10/27/20210.38USD1.43 BUSD2021 Q3
7/28/20210.34USD1.34 BUSD2021 Q2
4/27/20210.32USD1.31 BUSD2021 Q1
2/23/20210.36USD1.3 BUSD2020 Q4
10/27/20200.32USD1.15 BUSD2020 Q3
8/4/20200.22USD939.49 MUSD2020 Q2
5/6/20200.22USD1.05 BUSD2020 Q1
3/4/20200.27USD1.06 BUSD2019 Q4

PPD shareholder structure

% Name
22.02569%
H&F Globe Investor LP
H&F Globe Investor LP
15.91487%
The Carlyle Group
The Carlyle Group
15.91487%
H&F Corporate Investors VIII Ltd
H&F Corporate Investors VIII Ltd
6.15814%
GIC Private Limited
GIC Private Limited
6.13262%
Abu Dhabi Investment Authority
Abu Dhabi Investment Authority
3.42223%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
3.03887%
Pentwater Capital Management LP
Pentwater Capital Management LP
1.66822%
Goldman Sachs & Company, Inc.
Goldman Sachs & Company, Inc.
1.55693%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
1.44138%
Fidelity International
Fidelity International
...

Frequently asked questions about PPD

PPD Inc is a leading global contract research organization (CRO) providing comprehensive, integrated drug development and laboratory services. Their business model revolves around offering end-to-end solutions to pharmaceutical and biotech companies, guiding them through the entire drug development process. PPD Inc offers a wide range of services including clinical research, data management, biostatistics, and regulatory affairs. With a focus on quality, efficiency, and innovation, PPD Inc helps clients accelerate the development of life-changing therapies. Through their extensive expertise, efficient processes, and strategic partnerships, PPD Inc plays a crucial role in advancing healthcare outcomes and bringing new treatments to patients worldwide.

All fundamentals and in-depth analysis of PPD

Our stock analysis for PPD Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PPD Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.